Cargando…
Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study
INTRODUCTION: Proton pump inhibitors (PPIs) are widely used for primary and secondary prevention of upper gastrointestinal bleeding. However, there remains controversy about the overall net clinical benefit of PPIs (omeprazole, rabeprazole, pantoprazole, lansoprazole) when coprescribed with direct o...
Autores principales: | Wang, Mei, Paterson, Michael, Thabane, Lehana, Siegal, Deborah, Mbuagbaw, Lawrence, Targownik, Laura, Holbrook, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196177/ https://www.ncbi.nlm.nih.gov/pubmed/35697453 http://dx.doi.org/10.1136/bmjopen-2021-057991 |
Ejemplares similares
-
Nonvitamin K oral anticoagulants with proton pump inhibitor cotherapy ameliorated the risk of upper gastrointestinal bleeding
por: Chaiyana, Parata, et al.
Publicado: (2023) -
Predictors of oral anticoagulant-associated adverse events in seniors transitioning from hospital to home: a retrospective cohort study protocol
por: Benipal, Harsukh, et al.
Publicado: (2020) -
Outcomes after corrective surgery for congenital dextro-transposition of the great arteries using the arterial switch technique: a protocol for a scoping systematic review
por: Mbuagbaw, Lawrence, et al.
Publicado: (2014) -
Considerations for use of direct oral anticoagulants in arterial disease
por: Siegal, Deborah M., et al.
Publicado: (2021) -
Pharmacological reversal of the direct oral anticoagulants—A comprehensive review of the literature
por: Shaw, Joseph R., et al.
Publicado: (2018)